Eric Rowinsky's Trading History
| BIIBBiogen | Jun 11, 2026 | Director | Uninformative Buy | ― | $6.55M | |
| VSTMVerastem | May 26, 2026 | Director | Uninformative Buy | ― | $513.49K | |
| FBIOFortress Biotech | Jan 03, 2024 | Director | Uninformative Buy | ― | $132.09K | |
| NAVBQNavidea | Feb 22, 2018 | Director | Uninformative Buy | ― | $13.66K | |
| STMLStemline Therapeutics | Apr 28, 2015 | ― | Informative Sell | 170.69K | $1.70M | |
| SVRASavara | ― | Director | ― | $0.00 | ||
| BINDQDNIB Unwind, Inc. | ― | ― | ― | $0.00 |
You May Also Like
Eric Rowinsky insider profile FAQ
What is the percentage of profitable transactions made by Eric Rowinsky?
The percentage of profitable transactions made by Eric Rowinsky is 43%.
What is the average return per transaction made by Eric Rowinsky?
The average return per transaction made by Eric Rowinsky is 5.00%.
What stocks does Eric Rowinsky hold?
Eric Rowinsky holds: BIIB, VSTM, STML, FBIO, NAVBQ, BINDQ, SVRA stocks.
What was Eric Rowinsky's most profitable transaction?
Eric Rowinsky’s most profitable transaction was an Informative Sell of FBIO stock on April 9, 2021. The return on the trade was 77.00%.
What is Eric Rowinsky's role in Biogen?
Eric Rowinsky's role in Biogen is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.